Measuring the Effects of Berberine on Serum Prooxidant-Antioxidant Balance in Metabolic Syndrome.
Barberry
Metabolic syndrome
Natural products
Prooxidant–antioxidant balance
Reactive oxygen species
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
2
9
2021
pubmed:
3
9
2021
medline:
7
1
2022
Statut:
ppublish
Résumé
Disturbances in the prooxidant-antioxidant balance can occur in metabolic syndrome. Here, we present a protocol for the setup of a clinical trial of metabolic syndrome patients treated with berberine, a dietary phytochemical of the Berberis vulgaris plant, or placebo. The main aim is to obtain a quick and real-time assessment on the overall redox state based on measurement of the prooxidant-antioxidant balance.
Identifiants
pubmed: 34473333
doi: 10.1007/978-1-0716-1558-4_22
doi:
Substances chimiques
Antioxidants
0
Reactive Oxygen Species
0
Berberine
0I8Y3P32UF
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
309-318Informations de copyright
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S et al (2014) Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int 2014:761264. https://doi.org/10.1155/2014/761264
doi: 10.1155/2014/761264
pubmed: 24587990
pmcid: 3920909
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84
doi: 10.1016/j.biocel.2006.07.001
Rani V, Deep G, Singh RK, Palle K, Yadav UC (2016) Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci 148:183–193
doi: 10.1016/j.lfs.2016.02.002
Prasad K (2019) AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease. Mol Cell Biochem 459(1–2):95–112
doi: 10.1007/s11010-019-03553-4
Kohan R, Collin A, Guizzardi S, Tolosa de Talamoni N, Picotto G (2020) Reactive oxygen species in cancer: a paradox between pro- and anti-tumour activities. Cancer Chemother Pharmacol 86(1):1–13
doi: 10.1007/s00280-020-04103-2
Naziroğlu M, Butterworth PJ (2005) Protective effects of moderate exercise with dietary vitamin C and E on blood antioxidative defense mechanism in rats with streptozotocin-induced diabetes. Can J Appl Physiol 30:172–185
doi: 10.1139/h05-113
Darroudi S, Fereydouni N, Tayefi M, Ahmadnezhad M, Zamani P, Tayefi B et al (2019) Oxidative stress and inflammation, two features associated with a high percentage body fat, and that may lead to diabetes mellitus and metabolic syndrome. Biofactors 45(1):35–42
doi: 10.1002/biof.1459
Alberti KGMM, Zimmet PZ, Shaw JE (2005) The metabolic syndrome—a new world-wide definition from the International Diabetes Federation Consensus. Lancet 366(9491):1059–1062
doi: 10.1016/S0140-6736(05)67402-8
(2007) The IDF consensus definition of the metabolic syndrome in children and adults. file:///C:/Users/Lenovo%20User/Downloads/Mets_definition_children%20(1).pdf
GBD 2015 Obesity Collaborators; Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K et al (2015) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377(1):13–27
https://www.who.int/news-room/fact-sheets/detail/diabetes
Cooper ID, Crofts CAP, DiNicolantonio JJ, Malhotra A, Elliott B, Kyriakidou Y et al (2020) Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management. Open Heart 7(2):e001356. https://doi.org/10.1136/openhrt-2020-001356
doi: 10.1136/openhrt-2020-001356
pubmed: 32938758
Cornejo-Pareja IM, Gómez-Pérez AM, Fernández-García JC, Barahona San Millan R, Aguilera Luque A, de Hollanda A et al (2020) Coronavirus disease 2019 (COVID-19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease. Eur Eat Disord Rev 28(6):799–815. https://doi.org/10.1002/erv.2770
doi: 10.1002/erv.2770
pubmed: 32974994
Huang Y, Lu Y, Huang YM, Wang M, Ling W, Sui Y et al (2020) Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism 113:154378. https://doi.org/10.1016/j.metabol.2020.154378
doi: 10.1016/j.metabol.2020.154378
pubmed: 33002478
pmcid: 7521361
Ahmadnezhad M, Arefhosseini SR, Parizadeh MR, Tavallaie S, Tayefi M, Darroudi S et al (2018) Association between serum uric acid, high sensitive C-reactive protein and pro-oxidant-antioxidant balance in patients with metabolic syndrome. Biofactors 44(3):263–271
doi: 10.1002/biof.1424
Timar A, Saberi-Karimian M, Ghazizadeh H, Reza Parizadeh SM, Sabbaghzadeh R, Emadzadeh M et al (2019) Evaluation of the serum prooxidant-antioxidant balance before and after vitamin D supplementation in adolescent Iranian girls. Adv Med Sci 64(1):174–180
doi: 10.1016/j.advms.2018.10.004
Nobakht Motlagh Ghoochani BF, Ghafourpour M, Abdollahi F, Tavallaie S (2019) Pro-oxidant antioxidant balance in patients with non-alcoholic fatty liver disease. Gastroenterol Hepatol Bed Bench 12(2):124–130
pubmed: 31191836
pmcid: 6536017
Ghazizadeh H, Kathryn Bohn M, Ghaffarian Zirak R, Kamel Khodabandeh A, Zare-Feyzabadi R, Saberi-Karimian M et al (2020) Comprehensive laboratory reference intervals for routine biochemical markers and pro-oxidant-antioxidant balance (PAB) in male adults. J Clin Lab Anal 28:e23470. https://doi.org/10.1002/jcla.23470
doi: 10.1002/jcla.23470
Taghipour YD, Hajialyani M, Naseri R, Hesari M, Mohammadi P, Stefanucci A et al (2019) Nanoformulations of natural products for management of metabolic syndrome. Int J Nanomedicine 14:5303–5321
doi: 10.2147/IJN.S213831
Gundogdu M (2013) Determination of antioxidant capacities and biochemical compounds of Berberis vulgaris L. fruits. Adv Environ Biol 7(2):344–348
Arayne MS, Sultana N, Bahadur SS (2007) The berberis story: Berberis vulgaris in therapeutics. Pak J Pharm Sci 20(1):83–92
pubmed: 17337435
Hajzadeh M, Rajaei Z, Shafiee S, Alavinejhad A, Samarghandian S, Ahmadi M (2011) Effect of barberry fruit (Berberis vulgaris) on serum glucose and lipids in streptozotocin-diabetic rats. Clin Biochem 44(13). https://doi.org/10.1016/j.clinbiochem.2011.08.825
Potdar D, Hirwani RR, Dhulap S (2012) Phyto-chemical and pharmacological applications of Berberis aristata. Fitoterapia 83(5):817–830
doi: 10.1016/j.fitote.2012.04.012
Yang H, Tian T, Wu D, Guo D, Lu J (2019) Prevention and treatment effects of edible berries for three deadly diseases: cardiovascular disease, cancer and diabetes. Crit Rev Food Sci Nutr 59(12):1903–1912
doi: 10.1080/10408398.2018.1432562
Mohammadi A, Sahebkar A, Kermani T, Zhilaee M, Tavallaie S, Mobarhan MG (2014) Barberry administration and pro-oxidant-antioxidant balance in patients with metabolic syndrome. Iran Red Crescent Med J 16(12):e16786. https://doi.org/10.5812/ircmj.16786
doi: 10.5812/ircmj.16786
pubmed: 25763235
pmcid: 4341350
Yao J, Kong W, Jiang J (2015) Learning from berberine: treating chronic diseases through multiple targets. Sci China Life Sci 58(9):854–859
doi: 10.1007/s11427-013-4568-z
Yin J, Zhang H, Ye J (2008) Traditional Chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disord Drug Targets 8(2):99–111
doi: 10.2174/187153008784534330
Wang Y, Huang Y, Lam KS, Li Y, Wong WT, Ye H et al (2009) Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res 82(3):484–492
doi: 10.1093/cvr/cvp078
Xia X, Weng J (2010) Targeting metabolic syndrome: candidate natural agents. J Diabetes 2(4):243–249
doi: 10.1111/j.1753-0407.2010.00090.x
Zarei A, Changizi-Ashtiyani S, Taheri S, Ramezani M (2015) A quick overview on some aspects of endocrinological and therapeutic effects of Berberis vulgaris L. Avicenna. J Phytomed 5(6):485–497
Habtemariam S (2020) The quest to enhance the efficacy of berberine for type-2 diabetes and associated diseases: physicochemical modification approaches. Biomedicine 8(4):90. https://doi.org/10.3390/biomedicines8040090
doi: 10.3390/biomedicines8040090
Alamdari DH, Paletas K, Pegiou T, Sarigianni M, Befani C, Koliakos G (2007) A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 40(3–4):248–254
doi: 10.1016/j.clinbiochem.2006.10.017
Firouzi S, Malekahmadi M, Ghayour-Mobarhan M, Ferns G, Rahimi HR (2018) Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action. Diabetes Metab Syndr Obes 11:699–705
doi: 10.2147/DMSO.S181572
Sharma H, Kumar P, Deshmukh RR, Bishayee A, Kumar S (2018) Pentacyclic triterpenes: new tools to fight metabolic syndrome. Phytomedicine 50:166–177
doi: 10.1016/j.phymed.2018.09.011
Hedayati N, Bemani Naeini M, Mohammadinejad A, Mohajeri SA (2019) Beneficial effects of celery (Apium graveolens) on metabolic syndrome: a review of the existing evidences. Phytother Res 33(12):3040–3053
doi: 10.1002/ptr.6492
Calvano A, Izuora K, Oh EC, Ebersole JL, Lyons TJ, Basu A (2019) Dietary berries, insulin resistance and type 2 diabetes: an overview of human feeding trials. Food Funct 10(10):6227–6243
doi: 10.1039/C9FO01426H
Huang J, Qin S, Huang L, Tang Y, Ren H, Hu H (2019) Efficacy and safety of Rhizoma curcumea longae with respect to improving the glucose metabolism of patients at risk for cardiovascular disease: a meta-analysis of randomised controlled trials. J Hum Nutr Diet 32(5):591–606
doi: 10.1111/jhn.12648